Nguyen Phung Nguyen The, Thuc Tran Thanh, Hung Nguyen Thanh, Hao Nguyen Tri, Viet Nguyen Minh Tri, Phuong Nguyen Thi Ngoc, Trang Vu Thi Thuy, Hieu Le Minh, Bang Phan Dai, Thao Nguyen Thi Mai, Thu Huynh Nguyen Anh
University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Children's Hospital 1, Ho Chi Minh City, Vietnam.
Eur J Pediatr. 2025 Mar 3;184(3):221. doi: 10.1007/s00431-025-06051-6.
Cardiac injury is the critical issue in children with MIS-C, particularly coronary artery dilation. This study aimed to describe the prevalence, risk factors associated with coronary artery abnormalities, and their progression after 3 months of follow-up in MIS-C children in Vietnam. A prospective multicenter case series study was conducted on MIS-C patients diagnosed per WHO criteria from September 2021 to February 2023 at the two largest pediatric hospitals in southern Vietnam. Data on demographics, clinical features, laboratory findings, and treatments during the acute phase of MIS-C were collected. Patients were followed for 3 months post-discharge and categorized into normal and abnormal coronary artery groups for comparative analysis. Among 195 patients (mean age 6.3 years; male to female ratio 1.5:1), 33.3% exhibited coronary artery abnormalities at admission. Treatment included a combination of intravenous immunoglobulin (IVIG) and corticosteroids (53.3%), corticosteroids alone (42.6%), and IVIG alone (4.1%). After 3 months, only 3.6% of patients had persistent coronary artery abnormalities. Independent risk factors for coronary artery dilation included male sex (OR 4.59; 95% CI 1.62-12.94; p = 0.004), Kawasaki-like phenotype (OR 6.42; 95% CI 2.25-18.33; p = 0.001), and mesenteric lymphadenitis (OR 8.79; 95% CI 1.74-44.31; p = 0.008).
Coronary artery dilation in MIS-C patients shows a favorable recovery trajectory after a 3-month follow-up. Male sex, Kawasaki-like MIS-C, and mesenteric lymphadenitis are independent risk factors for coronary artery dilation in MIS-C patients.
• Multisystem inflammatory syndrome in children (MIS-C) is a severe inflammatory syndrome following SARS-CoV-2 infection, often leading to cardiac complications, particularly coronary artery dilation.
• Coronary artery dilation in MIS-C patients mostly resolves within three months of follow-up. Factors associated with coronary artery dilation in MIS-C patients include: male sex, Kawasaki-like phenotype and mesenteric lymphadenitis.
心脏损伤是儿童多系统炎症综合征(MIS-C)中的关键问题,尤其是冠状动脉扩张。本研究旨在描述越南MIS-C儿童中冠状动脉异常的患病率、相关危险因素及其在随访3个月后的进展情况。对2021年9月至2023年2月期间在越南南部两家最大的儿科医院按照世界卫生组织标准诊断为MIS-C的患者进行了一项前瞻性多中心病例系列研究。收集了MIS-C急性期的人口统计学、临床特征、实验室检查结果及治疗数据。患者出院后随访3个月,并分为冠状动脉正常组和异常组进行对比分析。在195例患者(平均年龄6.3岁;男女比例1.5:1)中,33.3%在入院时表现出冠状动脉异常。治疗包括静脉注射免疫球蛋白(IVIG)和皮质类固醇联合使用(53.3%)、单独使用皮质类固醇(42.6%)以及单独使用IVIG(4.1%)。3个月后,仅有3.6%的患者冠状动脉异常持续存在。冠状动脉扩张的独立危险因素包括男性(比值比4.59;95%置信区间1.62 - 12.94;p = 0.004)、川崎样表型(比值比6.42;95%置信区间2.25 - 18.33;p = 0.001)和肠系膜淋巴结炎(比值比8.79;95%置信区间1.74 - 44.31;p = 0.008)。
MIS-C患者的冠状动脉扩张在随访3个月后显示出良好的恢复轨迹。男性、川崎样MIS-C和肠系膜淋巴结炎是MIS-C患者冠状动脉扩张的独立危险因素。
• 儿童多系统炎症综合征(MIS-C)是一种在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染后出现的严重炎症综合征,常导致心脏并发症,尤其是冠状动脉扩张。
• MIS-C患者的冠状动脉扩张大多在随访3个月内消退。与MIS-C患者冠状动脉扩张相关的因素包括:男性、川崎样表型和肠系膜淋巴结炎。